Bone cancer research funded
By Hudson Institute communications
Bone cancer treatments will be progressed thanks to the Victorian Cancer Agency Early Career Fellowship, which has been awarded to Dr Vijesh Vaghjiani, Postdoctoral Scientist, Developmental and Cancer Biology Research group.
Dr Vaghjiani has been awarded $330,000 from 2021 to 2023 to support his research which seeks to improve the lives of patients, most of whom are children and adolescents, with a type of bone cancer known as osteosarcoma.
The Victorian Cancer Agency Early Career Research Fellowship is designed to support early career researchers undertaking high quality translational cancer research.
“Osteosarcoma is a devastating disease with limited treatment options that were developed in 1970s and remain unchanged,” Dr Vaghjiani said. “This project aims to develop and validate targeted therapies that would lead to better outcomes for patients and increased survival rates.”
About Hudson Institute
Hudson Institute’ s research programs deliver in three areas of medical need – inflammation, cancer, women’s and newborn health. More
Hudson News
Get the inside view on discoveries and patient stories
“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”